Boehringer Ingelheim's animal health marks 15 years of success in Việt Nam


Boehringer Ingelheim, a leading research-driven biopharmaceutical company in Việt Nam has commemorated the 15th anniversary of its animal health business in Việt Nam.

Dr. Armin Wiesler, Country Managing Director and Head of Animal Health, Regional Operating Unit ASEAN, Korea, Australia & New Zealand. — Photo courtesy of the company

Boehringer Ingelheim, a leading research-driven biopharmaceutical company in Việt Nam has commemorated the 15th anniversary of its animal health business in Việt Nam.

This milestone highlights the company’s commitment to customer-centricity and collaboration in delivering first-in-class innovative solutions for the livestock and companion animal segments.

Since its establishment in 2008, the animal health business in Việt Nam has forged strong relationships and partnerships with its customers and business partners.

Dr. Armin Wiesler, Country Managing Director and Head of Animal Health, Regional Operating Unit ASEAN, Korea, Australia & New Zealand, said: “This anniversary serves as a testament to the unwavering trust and support of our customers and business partners. Their collaboration has been instrumental in our journey towards sustainable growth and enhanced health care for animals in Việt Nam.”

Driven by the purpose of bringing “Value through innovation”, Boehringer Ingelheim has launched more than 40 animal health products over the past 15 years in Việt Nam. The company‘s portfolio includes vaccines, parasite-control products, therapeutics complemented by diagnostics and monitoring platforms to help protect and treat disease in pets and livestock.

Dr. Torsten Hardge, Director of Animal Health, Boehringer Ingelheim Vietnam, said: “Innovation and our expertise in animal health are at the core of Boehringer Ingelheim’s business activities globally and in Việt Nam. As a result, we are positively impacting the lives of animals and humans in Việt Nam.”

Apart from the relentless effort to bring innovative pharmaceutical solutions for humans and animals, Boehringer Ingelheim commits to contribute its expertise and heritage to make meaningful advances towards rabies elimination especially in underserved communities.

Through the STOP Rabies programme in Việt Nam, in collaboration with the Department of Agriculture and Rural Development in Đức Huệ District People's Committee, 20,000 dogs and cats have been vaccinated against rabies since 2021 and are on track to eliminate dog-mediated rabies in the Long An Province by 2025.

In addition, 1,000 students have been educated about rabies and dog bite prevention, in efforts to raise awareness and knowledge about rabies in communities, especially among children. — VNS

  • Share: